These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17316191)

  • 61. Sustainability of remission of pediatric primary nocturnal enuresis--comparison of remission using Try for Dry vs. non-Try for Dry treatment plans.
    Saldano DD; Chaviano AH; Maizels M
    Urol Nurs; 2008 Aug; 28(4):263-6. PubMed ID: 18771159
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nocturnal enuresis and overweight are associated with obstructive sleep apnea.
    Barone JG; Hanson C; DaJusta DG; Gioia K; England SJ; Schneider D
    Pediatrics; 2009 Jul; 124(1):e53-9. PubMed ID: 19564269
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Do holding exercises or antimuscarinics increase maximum voided volume in monosymptomatic nocturnal enuresis? A randomized controlled trial in children.
    Van Hoeck KJ; Bael A; Van Dessel E; Van Renthergem D; Bernaerts K; Vandermaelen V; Lax H; Hirche H; van Gool JD
    J Urol; 2007 Nov; 178(5):2132-6. PubMed ID: 17870123
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Assessment and treatment of nocturnal enuresis in children and young people.
    Richardson D
    Nurs Child Young People; 2018 Sep; 30(5):40-47. PubMed ID: 30178950
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nocturnal enuresis in children and young people: NICE clinical guideline.
    O'Flynn N
    Br J Gen Pract; 2011 May; 61(586):360-2. PubMed ID: 21619772
    [No Abstract]   [Full Text] [Related]  

  • 66. Improving the cure rate of alarm treatment for monosymptomatic nocturnal enuresis by increasing bladder capacity--a randomized controlled trial in children.
    Van Hoeck KJ; Bael A; Lax H; Hirche H; Bernaerts K; Vandermaelen V; van Gool JD
    J Urol; 2008 Mar; 179(3):1122-6; discussion 1126-7. PubMed ID: 18206946
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nocturnal Enuresis.
    Walker RA
    Prim Care; 2019 Jun; 46(2):243-248. PubMed ID: 31030825
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation and treatment of enuresis.
    Ramakrishnan K
    Am Fam Physician; 2008 Aug; 78(4):489-96. PubMed ID: 18756657
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structured desmopressin withdrawal improves response and treatment outcome for monosymptomatic enuretic children.
    Marschall-Kehrel D; Harms TW;
    J Urol; 2009 Oct; 182(4 Suppl):2022-6. PubMed ID: 19695616
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tips for managing treatment-resistant enuresis.
    Caldwell PH
    J Paediatr Child Health; 2018 Oct; 54(10):1060-1064. PubMed ID: 30294999
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Influence of pelvic floor muscle exercises on full spectrum therapy for nocturnal enuresis.
    Van Kampen M; Lemkens H; Deschamps A; Bogaert G; Geraerts I
    J Urol; 2009 Oct; 182(4 Suppl):2067-71. PubMed ID: 19695646
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Editorial comment.
    Skoog SJ
    J Urol; 2015 Feb; 193(2):661; discussion 661. PubMed ID: 25540109
    [No Abstract]   [Full Text] [Related]  

  • 73. Examination of the structured withdrawal program to prevent relapse of nocturnal enuresis.
    Butler RJ; Holland P; Robinson J
    J Urol; 2001 Dec; 166(6):2463-6. PubMed ID: 11696813
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Urinary nerve growth factor can predict therapeutic efficacy in children with monosymptomatic nocturnal enuresis.
    Morizawa Y; Aoki K; Iemura Y; Hori S; Gotoh D; Fukui S; Nakai Y; Miyake M; Torimoto K; Tanaka N; Fujimoto K
    Neurourol Urodyn; 2019 Nov; 38(8):2311-2317. PubMed ID: 31432572
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Management of enuresis in children and adolescents: summary of the NICE guideline].
    Delgado Nunes V; O'Flynn N; Evans J; Sawyer L
    Praxis (Bern 1994); 2011 May; 100(11):649-52. PubMed ID: 21614763
    [No Abstract]   [Full Text] [Related]  

  • 76. Follow up after middle-ear ventilation tube insertion: what is needed and when?
    Spielmann PM; McKee H; Adamson RM; Thiel G; Schenk D; Hussain SS
    J Laryngol Otol; 2008 Jun; 122(6):580-3. PubMed ID: 18047760
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray.
    De Guchtenaere A; Raes A; Vande Walle C; Hoebeke P; Van Laecke E; Donckerwolcke R; Vande Walle J
    J Urol; 2009 Jan; 181(1):302-9; discussion 309. PubMed ID: 19013601
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
    Robson WL; Leung AK; Norgaard JP
    J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of wireless and wired alarm devices for nocturnal enuresis treatment.
    Watanabe T; Ikeda H; Ono T; Oyake C; Watanabe Y; Fuyama M
    Pediatr Int; 2022 Jan; 64(1):e15328. PubMed ID: 36331235
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The frequency of constipation in children with nocturnal enuresis: a comparison with parental reporting.
    McGrath KH; Caldwell PH; Jones MP
    J Paediatr Child Health; 2008 Jan; 44(1-2):19-27. PubMed ID: 17854414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.